Gupta R, Estrella M, Scherzer R, Brewster P, Dworkin L, Nguyen H
Kidney Med. 2025; 7(2):100948.
PMID: 39895851
PMC: 11787008.
DOI: 10.1016/j.xkme.2024.100948.
Edgar B, Pearson R, Jackson A, Stove C, Kasthuri R, Hussey K
Sci Rep. 2025; 15(1):3475.
PMID: 39875455
PMC: 11775112.
DOI: 10.1038/s41598-025-86663-y.
Lubas A, Zegadlo A, Frankowska E, Jedrych E, Lubas T, Grzywacz A
J Clin Med. 2024; 13(17).
PMID: 39274236
PMC: 11395791.
DOI: 10.3390/jcm13175022.
OKeeffe H, Green D, de Bhailis A, Chinnadurai R, Wheatley K, Moss J
Circ Cardiovasc Interv. 2024; 17(9):e013979.
PMID: 39145377
PMC: 11404757.
DOI: 10.1161/CIRCINTERVENTIONS.123.013979.
Seydoux C, Hemett O, Periard D, Descombes E
SAGE Open Med Case Rep. 2023; 11:2050313X231209639.
PMID: 37941982
PMC: 10629318.
DOI: 10.1177/2050313X231209639.
Revascularization for Renovascular Disease: A Scientific Statement From the American Heart Association.
Bhalla V, Textor S, Beckman J, Casanegra A, Cooper C, Kim E
Hypertension. 2022; 79(8):e128-e143.
PMID: 35708012
PMC: 11731842.
DOI: 10.1161/HYP.0000000000000217.
Atherosclerotic Renovascular Disease: A KDIGO (Kidney Disease: Improving Global Outcomes) Controversies Conference.
Hicks C, Clark T, Cooper C, de Bhailis A, De Carlo M, Green D
Am J Kidney Dis. 2021; 79(2):289-301.
PMID: 34384806
PMC: 9834909.
DOI: 10.1053/j.ajkd.2021.06.025.
Cell-based regenerative medicine for renovascular disease.
Lerman L
Trends Mol Med. 2021; 27(9):882-894.
PMID: 34183258
PMC: 8403163.
DOI: 10.1016/j.molmed.2021.06.004.
Use of percutaneous transluminal renal angioplasty in atherosclerotic renal artery stenosis: a systematic review and meta-analysis.
Chen Y, Pan H, Luo G, Li P, Dai X
J Int Med Res. 2021; 49(1):300060520983585.
PMID: 33478308
PMC: 7841243.
DOI: 10.1177/0300060520983585.
Renal fibrosis detected by diffusion-weighted magnetic resonance imaging remains unchanged despite treatment in subjects with renovascular disease.
Ferguson C, Eirin A, Abumoawad A, Saad A, Jiang K, Hedayat A
Sci Rep. 2020; 10(1):16300.
PMID: 33004888
PMC: 7530710.
DOI: 10.1038/s41598-020-73202-0.
How should we define appropriate patients for percutaneous transluminal renal angioplasty treatment?.
Iwashima Y, Ishimitsu T
Hypertens Res. 2020; 43(10):1015-1027.
PMID: 32572170
DOI: 10.1038/s41440-020-0496-z.
Rediscovering Renovascular Hypertension.
Textor S, Taler S
Hypertension. 2019; 74(6):1297-1299.
PMID: 31656097
PMC: 6897319.
DOI: 10.1161/HYPERTENSIONAHA.119.13515.
Renovascular Hypertension.
Herrmann S, Textor S
Endocrinol Metab Clin North Am. 2019; 48(4):765-778.
PMID: 31655775
PMC: 7184322.
DOI: 10.1016/j.ecl.2019.08.007.
Impact of Renal Function Trajectory on Renal Replacement Therapy and Mortality Risk after Renal Artery Revascularization.
Takahashi E, Harmsen W, Misra S
J Vasc Interv Radiol. 2019; 31(4):592-597.
PMID: 31530493
PMC: 7069799.
DOI: 10.1016/j.jvir.2019.07.025.
Blood pressure decreases after revascularization in atherosclerotic renal artery disease: A cohort study based on a multidisciplinary meeting.
Sens F, Normand G, Fournier T, Della-Schiava N, Luong S, Pelletier C
PLoS One. 2019; 14(6):e0218788.
PMID: 31233539
PMC: 6590822.
DOI: 10.1371/journal.pone.0218788.
Prediction of cardiovascular outcomes with machine learning techniques: application to the Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) study.
Chen T, Brewster P, Tuttle K, Dworkin L, Henrich W, Greco B
Int J Nephrol Renovasc Dis. 2019; 12:49-58.
PMID: 30962703
PMC: 6433104.
DOI: 10.2147/IJNRD.S194727.
Impact of Serum Uric Acid Levels on Outcomes following Renal Artery Revascularization in Patients with Renovascular Disease.
Chen X, Eirin A, Kane G, Misra S, Textor S, Lerman A
Int J Hypertens. 2019; 2019:3872065.
PMID: 30838132
PMC: 6374789.
DOI: 10.1155/2019/3872065.
Combination of Renal Angioplasty and Angiotensin-converting-enzyme Inhibitor Can Reduce Proteinuria in Patients with Bilateral Renal Artery Disease.
Toda H, Uchida H, Nakamura K, Takeuchi H, Kinomura M, Nakagawa K
Intern Med. 2019; 58(13):1917-1922.
PMID: 30799351
PMC: 6663532.
DOI: 10.2169/internalmedicine.2076-18.
Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.
Carey R, Calhoun D, Bakris G, Brook R, Daugherty S, Dennison-Himmelfarb C
Hypertension. 2018; 72(5):e53-e90.
PMID: 30354828
PMC: 6530990.
DOI: 10.1161/HYP.0000000000000084.
Current Concepts in the Treatment of Renovascular Hypertension.
Herrmann S, Textor S
Am J Hypertens. 2017; 31(2):139-149.
PMID: 28985335
PMC: 5861545.
DOI: 10.1093/ajh/hpx154.